Pituitary-adrenal axis hormones in early-onset versus late-onset panic disorder

References

• Abelson JL, Curtis GC, Cameron OG. 1996. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol. J Psychiatr Res. 30:79–93.
   PubMed Web of Science ®Google Scholar
• Abelson JL, Khan S, Liberzon I, Young EA. 2007. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety. 24:66–76.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders (5thed.). Arlington (VA): American Psychiatric Association.
   Google Scholar
• Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, et al. 2017. Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 18:162–214.
   PubMed Web of Science ®Google Scholar
• Battaglia M, Bertella S, Politi E, Bernardeschi L, Perna G, Gabriele A, Bellodi L. 1995. Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. Am J Psychiatry. 152:1362–1364.
   PubMed Web of Science ®Google Scholar
• Benatti B, Camuri G, Dell'Osso B, Cremaschi L, Sembira E, Palazzo C, Oldani L, Dobrea C, Arici C, Primavera D, et al. 2016. Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder? Int Clin Psychopharmacol. 31:347–352.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P. 1992. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 26:12–22.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Biggio G, Pisu MG, Bellodi L, Perna G, Bogdanovich-Djukic V, Purdy RH, Serra M. 2003. Neurosteroid secretion in panic disorder. Psychiatry Res. 118:107–116.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Mellado C, Alciati A, Pisu MG, Purdy RH, Zanone S, Perini G, Serra M, Serra M, Biggio G. 2005. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res. 135:185–190.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Perini G, Serra M, Pisu MG, Zanone S, Toffanin T, Milleri S, Garcia CS, Biggio G. 2013. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals. Psychoneuroendocrinology. 38:2234–2242.
   PubMed Web of Science ®Google Scholar
• Chambless DL, Caputo GC, Bright P, Gallagher R. 1984. Assessment of fear of fear in agoraphobics: the Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. J Consult Clin Psychol. 52:1090–1097.
   PubMed Web of Science ®Google Scholar
• Dell'Osso L, Marazziti D, Da Pozzo E, Conversano C, Baroni S, Massimetti G, Martini C, Carmassi C. 2012. Gender effect on the relationship between stress hormones and panic-agoraphobic spectrum dimensions in healthy subjects. CNS Spectr. 17:214–220.
   PubMed Web of Science ®Google Scholar
• Dresler T, Guhn A, Tupak SV, Ehlis AC, Herrmann MJ, Fallgatter AJ, Deckert J, Domschke K. 2013. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm (Vienna). 120:3–29.
   PubMed Web of Science ®Google Scholar
• Elnazer HY, Baldwin DS. 2014. Investigation of cortisol levels in patients with anxiety disorders: a structured review. Curr Top Behav Neurosci. 18:191–216.
   PubMedGoogle Scholar
• Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. 1989. Dehydroepiandrosterone-Sulfate/Cortisol ratio in panic disorder. Psychiatry Res. 28:345–350.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JB. 1998. Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-I/P, Version 2.0, 8/98 revision). New York: Biometric Research Department, New York State Psychiatric Institute.
   Google Scholar
• Goldstein RB, Wickramaratne PJ, Horwath E, Weissman MM. 1997. Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. Arch Gen Psychiatry. 54:271–278.
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Hamilton SP. 2002. The early-onset fearful panic attack as a predictor of severe psychopathology. Psychiatry Res. 109:71–79.
   PubMed Web of Science ®Google Scholar
• Gorman JM, Kent JM, Sullivan GM, Coplan JD. 2000. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 157:493–505.
   PubMed Web of Science ®Google Scholar
• Graeff FG, Garcia-Leal C, Del-Ben CM, Guimarães FS. 2005. Does the panic attack activate the hypothalamic-pituitary-adrenal axis? An Acad Bras Cienc. 77:477–491.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol. 32:50–55.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
   PubMed Web of Science ®Google Scholar
• Hoffart A, Hedley LM, Svanøe K, Langkaas TF, Sexton H. 2016. Agoraphobia with and without panic disorder: a 20-year follow-up of integrated exposure and psychodynamic therapy. J Nerv Ment Dis. 204:100–107.
   PubMed Web of Science ®Google Scholar
• Iketani T, Kiriike N, Stein MB, Nagao K, Minamikawa N, Shidao A, Fukuhara H. 2004. Patterns of axis II comorbidity in early-onset versus late-onset panic disorder in Japan. Compr Psychiatry. 45:114–120.
   PubMed Web of Science ®Google Scholar
• Katerndahl DA, Talamantes M. 2000. A comparison of persons with early- versus late onset panic attacks. J Clin Psychiatry. 61:422–427.
   PubMed Web of Science ®Google Scholar
• Klein DF. 1993. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry. 50:306–317.
   PubMed Web of Science ®Google Scholar
• Konishi Y, Tanii H, Otowa T, Sasaki T, Kaiya H, Okada M, Okazaki Y. 2014. The association of BDNF Val66Met polymorphism with trait anxiety in panic disorder. J Neuropsychiatry Clin Neurosci. 26:344–351.
   PubMed Web of Science ®Google Scholar
• Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. 1999. DHEA and DHEA-S: a review. J Clin Pharmacol. 39:327–348.
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Markianos M, Oulis P. 2015. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder. Psychiatry Res. 229:75–81.
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Markianos M, Vaidakis N, Papakostas YG, Oulis P. 2009. Caffeine challenge and breath-holding duration in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 33:41–44.
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Papageorgiou C, Markianos M. 2017. Associations of plasma leptin to clinical manifestations in reproductive aged female patients with panic disorder. Psychiatry Res. 255:161–166.
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Papageorgiou C, Markianos M. 2019. Associations of plasma testosterone with clinical manifestations in acute panic disorder. Psychoneuroendocrinology. 101:216–222.
   PubMed Web of Science ®Google Scholar
• Parker CR. Jr. 1999. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids. 64:640–647.
   PubMed Web of Science ®Google Scholar
• Petrowski K, Wintermann GB, Schaarschmidt M, Bornstein SR, Kirschbaum C. 2013. Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Int J Psychophysiol. 88:35–39.
   PubMed Web of Science ®Google Scholar
• Ramsawh HJ, Weisberg RB, Dyck I, Stout R, Keller MB. 2011. Age of onset, clinical characteristics, and 15-year course of anxiety disorders in a prospective, longitudinal, observational study. J Affect Disord. 132:260–264.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW. 1986. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry. 143:896–899.
   PubMed Web of Science ®Google Scholar
• Rupprecht R, di Michele F, Hermann B, Ströhle A, Lancel M, Romeo E, Holsboer F. 2001. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev. 37:59–67.
   PubMedGoogle Scholar
• Schat A, van Noorden MS, Noom MJ, Giltay EJ, van der Wee NJA, de Graaf R, Ten Have M, Vermeiren RRJMM, Zitman FG. 2016. A cluster analysis of early onset in common anxiety disorders. J Anxiety Disord. 44:1–8.
   PubMed Web of Science ®Google Scholar
• Schmidt NB, Norr AM, Korte KJ. 2014. Panic disorder and Agoraphobia: Considerations for DSM-V. Res Soc Work Pract. 24:57–66.
   Web of Science ®Google Scholar
• Segui J, Marquez M, Garcia L, Canet J, Salvador-Carulla L, Ortiz M. 1999. Differential clinical features of early-onset panic disorder. J Affect Disord. 54:109–117.
   PubMed Web of Science ®Google Scholar
• Seguı́ J, Salvador-Carulla L, Márquez M, Garcı̀a L, Canet J, Ortiz M, 2000. Differential clinical features of late-onset panic disorder. J Affect Disord. 57:115–124.
   PubMed Web of Science ®Google Scholar
• Stein MB, Uhde TW. 1988. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry. 24:322–330.
   PubMed Web of Science ®Google Scholar
• Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A. 2003. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry. 60:133–141.
   PubMed Web of Science ®Google Scholar
• Tait GR, McManus K, Bellavance F, Lara N, Chrapko W, Le Melledo JM. 2002. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology. 27:417–429.
   PubMed Web of Science ®Google Scholar
• Tibi L, van Oppen P, Aderka IM, van Balkom AJLM, Batelaan NM, Spinhoven P, Penninx BW, Anholt GE. 2013. Examining determinants of early and late age at onset in panic disorder: an admixture analysis. J Psychiatr Res. 47:1870–1875.
   PubMed Web of Science ®Google Scholar
• Venturello S, Barzega G, Maina G, Bogetto F. 2002. Premorbid conditions and precipitating events in early-onset panic disorder. Compr Psychiatry. 43:28–36.
   PubMed Web of Science ®Google Scholar